Sensitivity Enhancement in Magnetic Particle Imaging by Background Subtraction

Biomedical applications such as cell tracking and angiography require the detection of low concentrations of superparamagnetic iron oxide nanoparticles (SPIOs) for imaging purposes. Magnetic particle imaging (MPI) is a new technology which enables the quantitative and time-resolved localization of SPIO distributions. However, the minimum concentration at which the SPIOs can be reconstructed with a suitable quality still remains to be investigated. In this work we examine the background signals in raw data that were measured without any SPIOs in the scanner tube. We show that a background subtraction in combination with a frequency cutoff for the dynamic part of the background signal lowers the detection limit for SPIOs in MPI up to a factor of ten. In-vivo mouse experiments show that for early time points from when the tracer enters the vena cava a reconstructed image of sufficient quality can only be obtained when a background subtraction is performed.

[1]  Bernhard Gleich,et al.  2D model-based reconstruction for magnetic particle imaging. , 2010, Medical physics.

[2]  B Gleich,et al.  Weighted iterative reconstruction for magnetic particle imaging , 2010, Physics in medicine and biology.

[3]  Kevin R Minard,et al.  Optimizing magnetite nanoparticles for mass sensitivity in magnetic particle imaging. , 2011, Medical physics.

[4]  Saqlain A. Shah,et al.  Slew-rate dependence of tracer magnetization response in magnetic particle imaging. , 2014, Journal of applied physics.

[5]  Bo Zheng,et al.  Quantitative stem cell imaging with magnetic particle imaging , 2013, 2013 International Workshop on Magnetic Particle Imaging (IWMPI).

[6]  Thorsten M. Buzug,et al.  Limitations of measurement-based system functions in magnetic particle imaging , 2010, Medical Imaging.

[7]  Bernhard Gleich,et al.  Tomographic imaging using the nonlinear response of magnetic particles , 2005, Nature.

[8]  Thorsten M. Buzug,et al.  A Spectrometer for Magnetic Particle Imaging , 2009 .

[9]  H. Arami,et al.  Chitosan-Coated Iron Oxide Nanoparticles for Molecular Imaging and Drug Delivery , 2011 .

[10]  A. Pai,et al.  Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud? , 2012, Journal of blood medicine.

[11]  Thorsten M. Buzug,et al.  Magnetic Particle Imaging: An Introduction to Imaging Principles and Scanner Instrumentation , 2012 .

[12]  Kevin R Minard,et al.  Optimization of nanoparticle core size for magnetic particle imaging. , 2009, Journal of magnetism and magnetic materials.

[13]  Jürgen Rahmer,et al.  Fast MPI Demonstrator with Enlarged Field of View , 2010 .

[14]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[15]  Tobias Knopp,et al.  Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[16]  T. Schaeffter,et al.  Limits of detection of SPIO at 3.0 T using T2* relaxometry , 2005, Magnetic resonance in medicine.

[17]  Bernhard Gleich,et al.  MPI cell tracking: what can we learn from MRI? , 2011, Medical Imaging.

[18]  B Gleich,et al.  Three-dimensional real-time in vivo magnetic particle imaging , 2009, Physics in medicine and biology.

[19]  Bernhard Gleich,et al.  Analysis of a 3-D System Function Measured for Magnetic Particle Imaging , 2012, IEEE Transactions on Medical Imaging.

[20]  Hamed Arami,et al.  Intracellular performance of tailored nanoparticle tracers in magnetic particle imaging. , 2014, Journal of applied physics.